- Securities Code: 002793
Stock Abbreviation: Luoxin Pharmaceutical
Announcement Number: 2026-020
Announcement of Resolutions from the Third Meeting of the Sixth Board of Directors of Luoxin Pharmaceutical Group Co., Ltd.
The company and all members of the board of directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
I. Meeting Information
On April 3, 2026, the third meeting of the sixth board of directors of Luoxin Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") was held in the conference room on the third floor of the Management Center on Luoqi Road, Linyi High-tech Industrial Development Zone, Shandong Province, and in the conference room of the World Trade Center in Qiantan, Pudong New District, Shanghai, combining on-site voting and remote voting. The meeting notice was sent out on March 31, 2026, via telephone, personal delivery, and email. A total of 7 directors were supposed to attend, and all 7 directors were present. The company’s board secretary attended the meeting. Mr. Liu Zhenteng, the chairman of the board, presided over the meeting. The convening and holding of the meeting complied with the provisions of the Company Law of the People's Republic of China and other laws, regulations, normative documents, and the Articles of Association of Luoxin Pharmaceutical Group Co., Ltd., and was legal and valid.